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Abstract
We evaluated 1,359 adults newly diagnosed with HIV in Philadelphia in 2010-2011 to determine 
if diagnosis site (medical clinic, inpatient setting, counseling and testing center (CTC), 
correctional facility) impacted time to linkage to care (difference between date of diagnosis and 
first CD4/viral load). 1,093 patients (80%) linked to care: 86% diagnosed in medical clinics, 75% 
in inpatient settings, 62% in CTCs, and 44% in correctional facilities. Adjusting for other factors, 
diagnosis in inpatient settings, CTCs, and correctional facilities resulted in a 33% (adjusted hazard 
ratio=0.77, 95% confidence interval=0.64-0.92), 46% (0.56, 0.42-0.72), and 75% (0.25, 0.18-0.35) 
decrease in the probability of linkage compared to medical clinics, respectively.
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Introduction
Linkage to care is critical to achieving HIV viral suppression, and is a key component of the 
test-and-treat approach to HIV prevention.1 Accordingly, the United States (U.S.) National 
HIV/AIDS Strategy (NHAS) calls for immediate linkage to care after HIV diagnosis, and has 
set a goal of increasing the proportion of persons linked to care within 3 months of diagnosis 
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from 65% to 85%.2 To meet this goal, a better understanding of factors impacting linkage to 
care is needed.
Prior research have focused on patient factors associated with linkage to care, noting that 
uninsured individuals, injection drugs users, and persons with lower household incomes had 
delayed linkage compared to their counterparts.3-11 Few studies have examined how site of 
HIV diagnosis impacts linkage to care. Among 1,928 New York City residents newly 
diagnosed with HIV in 2003, individuals diagnosed at community testing sites, correctional 
facilities, and department of health sexually transmitted diseases clinics were less likely to 
link to care (define using laboratory data – CD4 cell count and HIV viral load) than those 
diagnosed at primary medical care clinics.8 However, this study was limited in that it was 
unable to differentiate between laboratory tests conducted at medical care sites versus other 
locations and did not evaluate linkage rates for individuals diagnosed in inpatient facilities.
The current analysis extends prior research by (1) using more recent data from a different 
geographic region, (2) employing an improved definition of linkage to care, and (3) 
examining linkage to care for persons diagnosed in inpatient facilities. In this way, we 
provide new information on how the site of HIV diagnosis influences linkage to care.
Methods
Data Source and Study Population
Data were extracted from the City of Philadelphia's Enhanced HIV/AIDS Reporting System 
(eHARS), a database containing demographic, laboratory, and health service utilization 
information on all HIV cases reported to the Philadelphia Department of Public Health. 
Philadelphia requires name-based case reporting of all new HIV infections in the City. In 
addition, local mandates require reporting of all CD4 cell counts <350 cell/mm3 and all 
HIV-1 RNA results. In 2012, the City started collecting information on all CD4 cell counts 
(not only those <350 cell/mm3) and retrospectively obtained data for 2009-2012.
All laboratory results, including reactive HIV Western blots, CD4 cell counts, and HIV-1 
RNA levels, are assigned a unique identifier indicating the facility associated with the 
requesting provider. Death data from the Pennsylvania Bureau of Vital Statistics, Social 
Security Death Master Index, and the National Death Index are routinely matched with 
eHARS data to identify deceased persons. The eHARS data are routinely monitored to 
identify duplicate cases, and undergo quality control and verification to ensure that 
abstracted data are correctly assigned to unique case records.
This analysis included all adults (≥18 years old) with a new HIV diagnosis (positive 
Western blot) in Philadelphia between 2010 and 2011. Cases were followed through 2012.
Predictor and Outcome Variables
For each person, we defined age, sex at birth, race/ethnicity, and HIV transmission risk at 
the time of HIV diagnosis. Age was divided into 4 groups: 18-29, 30-39, 40-49, and ≥50 
years old. Race/ethnicity was categorized as non-Hispanic white, non-Hispanic black, 
Hispanic, and other/unknown. HIV transmission risk was grouped into heterosexual, men 
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who have sex with men (MSM), injection drug use (IDU), and other/unknown. Patients who 
had IDU in combination with another risk factor (e.g. MSM, heterosexual transmission) 
were classified as IDU. Site of HIV diagnosis was categorized as medical care clinic; 
inpatient facility, including the emergency department (ED); counseling and testing center 
(CTC), sites offering HIV counseling and testing, but not outpatient medical care services; 
and correctional system.
We calculated the difference between date of HIV diagnosis (date of first positive Western 
blot) and date of entry into care (date of first CD4 cell count or HIV-1 RNA at a medical 
care clinic). CD4 cell count and HIV-1 RNA tests collected in inpatient and correctional 
facilities were excluded, as they did not represent linkage to outpatient primary HIV care. In 
exploratory analyses, we defined linkage as HIV laboratory testing at a medical care clinic 
or correctional facility. Timely linkage was classified as entering care within 3 months of 
diagnosis. For those linked to care, we calculated the median CD4 count at the time of entry 
into care.
Statistical Analyses
Comparisons of demographic characteristics of the sample across HIV diagnosis sites were 
made using the X2 test of independence. The proportion of cases linked to care (within 3 
months, after 3 months, and not linked) was assessed for each demographic characteristic 
and diagnosis site. A time-to-event analysis was conducted using days between HIV 
diagnosis and entry into care as the dependent variable. Patients contributed observation 
time from the date of diagnosis to the date of entry into care, or were censored at death or 
end of the study period (December 31, 2012). The Kaplan-Meier product-limit method was 
used to estimate the cumulative proportion entering care after HIV diagnosis, stratified by 
diagnosis site. In primary analyses, multivariate Cox proportional hazards regressionwas 
used to identify factors (age, sex, race/ethnicity, HIV transmission risk, year of diagnosis, 
site of HIV diagnosis) associated with time to entry into care and to calculate their adjusted 
hazard ratios (AHRs). In secondary analyses, multivariable logistic regression was used to 
examine the association between HIV diagnosis site and timely linkage to care (within 3 
months of diagnosis), adjusting for patient characteristics. Two-sided testing was used, with 
a P-value of <0.05 considered significant. Analyses were conducted using STATA 12.1 
(College Station, TX).
Results
Between 2010 and 2011, 1,359 individuals were newly diagnosed with HIV; 74% were 
male, 68% were black, and 60% were 18-39 years old. The majority of patients had HET 
(46%) or MSM (41%) as their HIV risk behavior. Seventy-three percent of the sample was 
diagnosed in a medical care clinic, 15% in an inpatient setting, 7% in a CTC, and 6% in a 
correctional facility. (Table 1)
Young adults (18-29 years) and those with MSM risk were more likely to be diagnosed at a 
medical care clinic or CTC than older individuals and those with HET or IDU risk (p<0.05). 
Males, 30-49 years old, and those with HET or IDU risk were diagnosed at higher 
proportions in correctional facilities than their counterparts (p<0.05). While, older adults, 
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females, and those with HET or IDU risk were more likely to be diagnosed in an inpatient 
setting compared to younger individuals, males, and persons with MSM risk, respectively 
(p<0.05). (Table 1)
By the end of the study period, 1,093 (80%) newly diagnosed individuals linked to care: 821 
(60%) within 3 months and 272 (20%) after 3 months of diagnosis; 266 (20%) did not link 
to care. (Table 2) Median CD4 count at the time of entry into care was 351 cell/mm3 for 
those who linked within 3 months and 382 cell/mm3 for those who linked after 3 months. 
Kaplan-Meier results demonstrate that persons diagnosed in medical care clinics had the 
highest proportion linked to care (86%), followed by those diagnosed in inpatient settings 
(75%) and CTCs (62%); persons diagnosed in correctional facilities had the lowest 
proportion linked to care (44%). (Appendix Figure) In analyses defining linkage as 
completion of HIV laboratory tests in medical care clinics or correctional facilities, 87% of 
persons diagnosed in medical care clinics were linked to care, 77% from inpatient settings, 
66% from CTCs, and 82% from correctional facilities; 67%, 54%, 53%, and 63% were 
linked to care within 3 months, respectively. (Appendix Table 1)
In multivariate analyses, diagnosis in inpatient settings, counseling and testing centers, and 
correctional facilities resulted in a 23% (AHR 0.77, 95% confidence interval 0.64-0.92), 
46% (0.56, 0.42-0.72), and 75% (0.25, 0.18-0.35) decrease in the hazard of linkage to care 
compared to diagnosis in medical care clinics, respectively. Additionally, the hazard of not 
linking to care was greater for black patients (vs. white), persons with IDU as their HIV risk 
factor (vs. heterosexual), and those diagnosed in 2010 (vs. 2011). (Table 2) Secondary 
analyses examining factors associated with timely linkage to care, within 3 month of HIV 
diagnosis, yielded similar results. (Appendix Table 2)
Discussion
These data, from a large geographic sample of people newly diagnosed with HIV, 
demonstrate that diagnosis at sites without co-located outpatient care, black race/ethnicity, 
and IDU risk behavior are strongly associated with delayed linkage to care. Our findings 
support those of earlier studies, noting higher linkage to care rates when HIV testing 
programs are co-located at medical care clinics.8,12 Moreover, they highlight the need to 
develop and evaluate effective interventions to facilitate linkage to care for HIV-infected 
individuals newly diagnosed in correctional facilities, counseling and testing centers, and 
inpatient/ED settings.
Rates of HIV testing among inmates have been reported between 73%-90%, in part due to 
the Centers for Disease Control and Prevention (CDC) recommendation to screen for HIV 
infection upon entry into prison and state policies mandating HIV testing during 
incarceration.13-15 However, linkage to care for ex-offenders is often challenging, reflecting 
both significant obligations individuals face after release from prison (e.g. addressing basic 
needs, finding employment, obtaining/renewing healthcare coverage) and limited support 
provided during this transition.15-20 In addition, untreated mental illness and drug addition, 
which are conditions commonly associated with incarceration, may continue after release 
compounding the challenges of linking to care.21 Despite these obstacles, programs such as 
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Project Bridge, a federally funded demonstration project that provided intensive case 
management for HIV-infected ex-offenders being released from prison to the community, 
have been shown to improve linkage to medical care for ex-offenders.21,22 In order to 
improve linkage rates among prisoners, Philadelphia has implemented a prison to 
community linkage program using case management services. Similar multifaceted 
approaches to addressing barriers to care and improving care coordination need to be 
implemented and evaluated.
From a measurement standpoint, additional studies are needed to evaluate the appropriate 
definition of linkage to care for persons diagnosed in correctional facilities. Our results 
demonstrated a near doubling of the proportion linked to care when linkage was defined as 
completion of HIV laboratory testing at a correctional facility or medical care clinic 
compared to medical care clinic alone (82% vs. 44%). While the proportion linked to care 
varies between the two methodologies, the central issue of ensuring a safe and effective 
transition from prison to the community for persons newly diagnosed during incarceration 
remains.18
Analogous to individuals newly diagnosed with HIV in prison, those diagnosed in hospital 
wards and EDs face multiple challenges to timely linkage to care. Prior data indicates that 
only half to two-thirds of patients fully understand their post-discharge treatment plan, and 
this lack of understanding impacts their ability to comply with discharge instructions, 
including follow-up appointments.23-26 While these issues are not unique to HIV-infected 
patients, persons with HIV may be less likely to link to care given the high prevalence of 
poverty, mental illness, and substance abuse in this population and the fear of stigma 
associated with HIV infection.27,28 Case management and patient navigation may be 
effective tools to improve the transition from inpatient to outpatient care.29
In contrast to inpatient and correctional facilities, persons diagnosed in medical care clinics 
had higher linkage rates. Integration of HIV testing and medical services may facilitate 
linkage to care, particularly for younger adults and MSMs, by decreasing appointment wait 
times, leveraging patients’ familiarity with the clinic environment and staff, and providing 
ancillary support services (e.g. case management, social work).8,30,31 Persons diagnosed at 
medical care clinics may also have fewer health care barriers, as demonstrated by their 
ability to navigate the healthcare system and access medical services.
Consistent with earlier studies, individuals with IDU transmission risk were less likely to 
link to care, both overall and within 3 months of diagnosis, than their counterparts.3,8,11 
Care coordination, case management, and co-location of medical and mental health/
substance abuse treatment programs have been identified as effective strategies for 
improving linkage to care, and may be particularly helpful in this population.28,32 We did 
not observe any differences in linkage to care between men and women. However, prior 
studies note mixed findings, with some noting that women are more likely to link to care 
than men and other demonstrating the opposite. 6,8 Additional research is warranted to 
determine the impact of gender on linkage to care.
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Prior studies indicate that lower household income and lack of health insurance coverage are 
associated with lower rates of linkage to care, which may reflect prioritization of basic needs 
(e.g. food, housing) over healthcare and challenges in navigating the healthcare system.3,4,9 
The Affordable Care Act, which expanded Medicaid coverage in some states to include all 
people with incomes up to 138% of the federal poverty level, may provide an opportunity to 
address some of these barriers and improve access to care.33 Persons with MSM risk (vs. 
heterosexual) had similar linkage rates overall, but were less likely to link to care within 3 
month of diagnosis. Paz-Bailey and colleagues evaluated linkage to care among 8,153 
MSMs in 21 U.S. cities, noting that lower income and testing positive at their first HIV test 
were associated with delayed linkage (>3 months after diagnosis) and age 18-29 years and 
not having insurance were associated with not linking to care at all.4 These findings 
demonstrate that differing factors impact timely linkage and non-linkage to care. Additional 
studies are needed to identify these differences and develop interventions to improve linkage 
to care, particularly among adolescents and the uninsured who represent a significant and 
growing portion of new HIV infections in the U.S.
Our study has several limitations. First, we relied on the use of laboratory data to define 
linkage to care. This may underestimate timely linkage (within 3 months of diagnosis) if 
laboratory tests were not ordered at or were drawn after the first HIV care visit. Second, we 
narrowly defined linkage to care as having evidence of laboratory testing at a medical care 
facility. Exclusion of laboratory tests collected outside these sites may explain why our 
linkage rates (particularly for those diagnosed in prison) were lower than reported 
elsewhere.15,17 Third, we were unable to distinguish laboratory tests conducted in the ED 
from those conducted on hospital wards. Given the high patient volume and turnover in 
EDs,34 additional studies evaluating the HIV testing and linkage processes in these settings 
are necessary. Fourth, information on the date of release from a correctional facility was not 
available, making inference on timely linkage to outpatient HIV care in the community 
difficult. Improving data sharing between correctional and surveillance systems may provide 
opportunities for future investigations in this area. Fifth, data from the CDC Routine 
Interstate Duplicate Review file indicates that 82 individuals relocated from Philadelphia 
during the study period (exact dates were not available and thus could not be included in 
Cox regression models). However, only 14 persons moving out of the City before linking to 
care; this small number is unlikely to significantly alter our results. Sixth, surveillance data 
does not capture certain patient and structure factors that may impact linkage to care (e.g. 
household income, insurance status, fear of stigma and discrimination, social supports, 
and comorbid conditions). Future studies should evaluate how these and other factors affect 
linkage to care. Lastly, generalizability was limited as we only studied HIV-infected 
individuals in one U.S. city, with high proportions of racial/ethnic minorities and low 
income individuals.35
Only 60% of our sample linked to care within 3 months of HIV diagnosis. Improving 
linkage to HIV care, particularly for individuals diagnosed at sites without co-located 
medical care, will be critical to realizing the treatment and prevention benefits of 
antiretroviral therapy, and for achieving the targets set in the NHAS.2
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